Patent application number | Description | Published |
20110212962 | P38 MAP KINASE INHIBITORS - There are provided inter alia compounds of formula (I) wherein R | 09-01-2011 |
20110269800 | P38 MAP KINASE INHIBITORS - There is provided a compound of formula (I) or a pharmaceutically acceptable salt or solvate thereof, including all tautomers thereof, compositions comprising the same, use of said compound and compositions for treatment, in particular for the treatment of asthma and COPD, and processes for the preparation of said compound. | 11-03-2011 |
20110294812 | P38 MAP KINASE INHIBITORS - The invention relates to compounds of formula (I): | 12-01-2011 |
20110312963 | P38 MAP KINASE INHIBITORS - The present disclosure relates to compounds of formula (I): | 12-22-2011 |
20120136031 | P38MAP KINASE INHIBITOR - The present invention relates to a compound of formula (I): | 05-31-2012 |
20120208799 | COMPOUNDS - The present invention relates to compounds of formula (I) | 08-16-2012 |
20130012512 | P38 MAP kinase inhibitors - There are provided inter alia compounds of formula (I) | 01-10-2013 |
20130029990 | PYRAZOLE P38 MAP KINASE INHIBITORS - There are provided inter alia compounds of formula (I): wherein R | 01-31-2013 |
20130040962 | P38 MAP Kinase Inhibitors - There is provided a compound of formula (I): wherein: J represents (A): or (B): compositions comprising same, processes for preparing said compounds and use thereof in treatment, particularly in the treatment of inflammatory disease, such as asthma, COPD and 15 rheumatoid arthritis. | 02-14-2013 |
20130040995 | NOVEL COMPOUNDS - There is provided inter alia a compound of formula (I): | 02-14-2013 |
20130156826 | RESPIRATORY FORMULATIONS AND COMPOUNDS FOR USE THEREIN - The present invention relates to respiratory formulations comprising a compound of formula (I): and use of said compounds and compositions in treatment, for example in the treatment of an inflammatory disease or a respiratory disorder, in particular an inflammatory mediated and/or virally mediated respiratory disorder such as asthma and COPD or the treatment or prevention of viral infection, for example infection by influenza virus, rhinovirus or RSV. The invention also extends to certain novel compounds of formula (I). | 06-20-2013 |
20130231355 | QUINAZOLIN-4 (3H)- ONE DERIVATIVES USED AS P13 KINASE INHIBITORS - The present invention relates to the compound of formula (I) | 09-05-2013 |
20140057915 | KINASE INHIBITORS - There are provided compounds of formula I, | 02-27-2014 |
20140114064 | P38 MAP KINASE INHIBITORS - There are provided inter alia compounds of formula (I) | 04-24-2014 |
20140249164 | COMPOUNDS - The present invention relates to compounds of formula (I) | 09-04-2014 |